Items where authors include "Anthoney, A."

Article

Corrie, P.G., Qian, W., Basu, B. et al. (31 more authors) (2020) Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. British Journal of Cancer, 122 (12). pp. 1760-1768. ISSN 0007-0920

Neoptolemos, J.P., Palmer, D.H., Ghaneh, P. et al. (32 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

Conference or Workshop Item

Lahu, G., Banerji, U., Tap, W.C. et al. (15 more authors) (2025) Abstract CT151: Comparative pharmacokinetics and tumor activation of fibroblast activation protein (FAP)-enabled pre|CISION® peptide drug conjugates. In: AACR Annual Meeting 2025, 25-30 Apr 2025, Chicago, Illinois.

Proceedings Paper

Banerji, U., Cook, N., Anthoney, A. et al. (11 more authors) (2024) Abstract CT188: A Phase I trial of AVA6000, a Fibroblast Activation Protein (FAP)-released and tumor microenvironment (TME)-targeted doxorubicin peptide drug conjugate in patients with FAP-positive solid tumors. In: Cancer Research. AACR Annual Meeting 2024, 05-10 Apr 2024, San Diego, USA. American Association for Cancer Research , ct188-ct188.